wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35040102-65A8DB5C-8A5D-4DCF-9256-49E0609CC383
Q35040102-65A8DB5C-8A5D-4DCF-9256-49E0609CC383
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35040102-65A8DB5C-8A5D-4DCF-9256-49E0609CC383
Effects of host and virus related factors on interferon-α+ribavirin and pegylated-interferon+ribavirin treatment outcomes in chronic Hepatitis C patients.
P2860
Q35040102-65A8DB5C-8A5D-4DCF-9256-49E0609CC383
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35040102-65A8DB5C-8A5D-4DCF-9256-49E0609CC383
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
d72af708fbdbec50be1914b7a62eace0f302bb38
P2860
Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (I